Folitrax 50MG Injection (2ml) is a potent medication that contains Methotrexate, a well-known antimetabolite and immunosuppressant. This injection is primarily used in the treatment of various conditions, including certain types of cancer, autoimmune diseases, and severe psoriasis. Methotrexate works by inhibiting the growth of rapidly dividing cells, making it effective in managing malignancies and inflammatory disorders. The formulation of Folitrax is designed for parenteral administration, allowing for direct delivery into the bloodstream, which can enhance its efficacy and reduce gastrointestinal side effects often associated with oral forms of the drug. As a critical component in chemotherapy regimens and a cornerstone in the management of rheumatoid arthritis, Folitrax 50MG Injection plays a vital role in modern medical therapies, providing patients with a means to control their conditions effectively.